Metraipolis › archive › dc_5495aae8ead4

Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and… — Europe PMC PMID:42513436

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42513436
DOI
10.3390/jcm15145521
License (as archived)
solo-consultazione
Archived
2026-10-18T07:20:31.726Z
SHA-256 of the archived text
73af71ee4cb688b49bc7cb46d72cdedfa703d7ed6d808dab36b770255de3ca99
Stable URL of this page
https://metraipolis.com/documento/dc_5495aae8ead4

How to cite

Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and… — Europe PMC PMID:42513436 — Europe PMC (en), https://europepmc.org/article/MED/42513436 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5495aae8ead4 (Metraipolis archive dc_5495aae8ead4, sha256 73af71ee4cb688b49bc7cb46d72cdedfa703d7ed6d808dab36b770255de3ca99)
BibTeX
@misc{dc5495aae8ead4,
  title = {Precision Therapeutics in Pancreatic Cancer: Emerging Targeted, Immune, and Antibody-Drug Conjugate Strategies Exemplified by Adagrasib, Dostarlimab, and… — Europe PMC PMID:42513436},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42513436},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5495aae8ead4; sha256 73af71ee4cb688b49bc7cb46d72cdedfa703d7ed6d808dab36b770255de3ca99},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42513436. Agents can read the archived copy with the MCP tool read_document.